Adeoye Olukotun: Director at Arrowhead Pharmaceuticals, Inc., stock sales and holdings

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

What the filings show, past 12 months. Nothing here rates or predicts.

Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Aug 2026.
Largest single sale: $414K (6,083 shares) of Arrowhead Pharmaceuticals, Inc. on Dec 19, 2025. Filing
Last sale before this period: Jan 23, 2025.

Every company we track where this person has filed, newest filing first.

Company	Title	First filing	Latest filing
Arrowhead Pharmaceuticals, Inc. (ARWR)	Director	Sep 8, 2020	Aug 20, 2026

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

Aug 18, 2026, Arrowhead Pharmaceuticals, Inc.: sold 2,000 shares for $174K, no plan disclosed. 1 filing: 1
Dec 19, 2025, Arrowhead Pharmaceuticals, Inc.: sold 10,000 shares for $677K, under a disclosed plan. 1 filing: 1
Dec 16, 2025, Arrowhead Pharmaceuticals, Inc.: 7,819 shares granted. 1 filing: 1

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.